NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 37 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,494,000 | -19.6% | 1,856,000 | 0.0% | 0.33% | -26.0% |
| Q2 2018 | $6,830,000 | +5.1% | 1,856,000 | 0.0% | 0.45% | -10.3% |
| Q1 2018 | $6,496,000 | +12.2% | 1,856,000 | 0.0% | 0.50% | -13.9% |
| Q4 2017 | $5,791,000 | -55.6% | 1,856,000 | 0.0% | 0.58% | -62.5% |
| Q3 2017 | $13,048,000 | -23.7% | 1,856,000 | +0.2% | 1.54% | -29.5% |
| Q2 2017 | $17,094,000 | -14.1% | 1,852,000 | 0.0% | 2.18% | -46.9% |
| Q1 2017 | $19,890,000 | +66.4% | 1,852,000 | +30.4% | 4.11% | +45.2% |
| Q4 2016 | $11,956,000 | – | 1,420,000 | – | 2.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 831,440 | $7,674,000 | 13.79% |
| Stonepine Capital Management, LLC | 1,852,395 | $17,098,000 | 9.23% |
| Sarissa Capital Management LP | 1,025,000 | $9,460,000 | 3.16% |
| Opaleye Management Inc. | 750,000 | $6,922,000 | 2.89% |
| Broadfin Capital, LLC | 1,948,554 | $17,985,000 | 2.18% |
| ARMISTICE CAPITAL, LLC | 1,852,000 | $17,094,000 | 2.18% |
| JW Asset Management, LLC | 315,980 | $2,916,000 | 1.86% |
| Tiger Legatus Capital Management, LLC | 450,000 | $4,154,000 | 1.69% |
| KNOTT DAVID M | 109,184 | $1,008,000 | 0.42% |
| Ancora Advisors LLC | 507,981 | $4,688,000 | 0.30% |